IC
STIM icon

Ikarian Capital’s Neuronetics STIM Stock Holding History

Ikarian Capital’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$912K Hold
701,182
– – 0.1% 108
2026
Q1 		$1.02M Hold
701,182
– – 0.08% 112
2025
Q4 		$968K Sell
701,182
-204,534
-23% -$428K 0.08% 127
2025
Q3 		$2.47M Sell
905,716
-193,984
-18% -$689K 0.25% 90
2025
Q2 		$3.84M Sell
1,099,700
-300
-0% -$1.18K 0.74% 41
2025
Q1 		$4.05M Buy
+1,100,000
New +$4.02M 0.5% 43

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Ikarian Capital's STIM Position: Q2 2026 in Review

Ikarian Capital held its Neuronetics (STIM) position steady in Q2 2026 at 701,182 shares worth $912K. The position accounts for 0.1% of the portfolio, ranked #108.

Ikarian Capital first reported a position in STIM in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.05M in Q1 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Ikarian Capital held 701,182 shares of Neuronetics worth $912K as of Q2 2026.
  • Ikarian Capital left its Neuronetics share count unchanged in Q2 2026.
  • Neuronetics made up 0.1% of Ikarian Capital's portfolio in Q2 2026, its #108 holding.
  • Ikarian Capital first reported a position in Neuronetics in Q1 2025 and has held it in 6 quarters since.
  • Ikarian Capital's Neuronetics position peaked at $4.05M in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.